ClinicalTrials.gg
CompletedNCT07922603ESEFA-PSDHRTUpdated Nov 6, 2026

Effects of Seated Exercise on Fatigue Associated With Prolonged Sitting During High-Speed Rail Travel

An interventional study of Standardized Age-Specific Seated Exercise Program and Prolonged Sitting Control in Sedentary Behavior, Fatigue and Prolonged Sitting, sponsored by Aiyoudong Children and Youth Sports Health Research Institute. Completed at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Aiyoudong Children and Youth Sports Health Research Institute · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Aug 2026, registered Nov 2026).
Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Prolonged sitting during high-speed rail travel may contribute to subjective fatigue, musculoskeletal discomfort, sleepiness, reduced alertness, cognitive impairment, and changes in physiological and neurophysiological function.

This randomized crossover controlled trial aims to evaluate the effects of a standardized age-specific seated exercise program on multidimensional fatigue associated with prolonged sitting during simulated high-speed rail travel.

Participants aged 7 to 60 years will be analyzed within three prespecified age groups: 7-18 years, 18-45 years, and 45-60 years. Each participant will complete both a seated exercise condition and a prolonged sitting control condition in randomized order.

Outcome measures will include subjective fatigue, sleepiness, local discomfort, mood, attention, psychomotor vigilance, working memory, inhibitory control, heart rate variability, salivary biomarkers, surface electromyography, plantar pressure and postural control measures, and electroencephalographic indices.

The study aims to determine whether brief standardized seated exercise performed periodically during prolonged sitting can reduce fatigue and maintain physical, cognitive, autonomic, and neurophysiological function during simulated high-speed rail travel.

Read the detailed description

The study will use a randomized crossover design to evaluate a standardized seated exercise program under simulated prolonged high-speed rail travel conditions. Each participant will complete two experimental sessions in randomized order: a seated exercise condition and a prolonged sitting control condition. The two sessions will be separated by a washout period of at least 7 days to minimize potential carryover effects.

Each experimental session will last approximately 7 hours in a simulated high-speed rail seating environment. Baseline assessments will be completed before prolonged sitting. During the seated exercise condition, participants will perform a standardized age-appropriate seated exercise program according to a predefined schedule, with exercise repeated approximately once every hour during the prolonged sitting period. During the control condition, participants will remain seated under the same environmental and assessment conditions without performing the structured exercise program.

Standardized breaks for essential needs, including drinking water, meals, and restroom use, will be permitted and recorded. The timing of experimental sessions, pre-test requirements, assessment procedures, and environmental conditions will be standardized as far as possible between the two study periods.

Participants will be stratified into three prespecified age groups (7-18 years, 18-45 years, and 45-60 years). Age-appropriate instructions and assessment procedures will be used for younger participants. For participants younger than 18 years, written informed consent will be obtained from a parent or legal guardian together with age-appropriate assent from the participant.

The study is designed to determine whether brief, repeated seated exercise can attenuate the multidimensional effects of prolonged sitting and help maintain subjective well-being, cognitive performance, autonomic regulation, neuromuscular function, postural control, and neurophysiological function during prolonged simulated high-speed rail travel.

02

Conditions studied

  • Sedentary Behavior
  • Fatigue
  • Prolonged Sitting

Keywords

  • Seated Exercise
  • Prolonged Sitting
  • High-Speed Rail
  • Travel Fatigue
  • Sedentary Behavior
  • Cognitive Fatigue
  • Heart Rate Variability
  • Electroencephalography
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's enrollment of 120 is above the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Aiyoudong Children and Youth Sports Health Research Institute is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male or female participants aged 7 to 60 years.
  2. Generally healthy and able to complete prolonged seated testing and the standardized seated exercise program.
  3. Able to understand and follow the study instructions and complete the required cognitive and physical assessments.
  4. Able to maintain a seated position for the experimental protocol, with standardized breaks permitted for essential needs.
  5. Willing to comply with study procedures and attend both crossover experimental sessions.
  6. Able to provide written .
  7. For participants younger than 18 years, written informed consent will be obtained from a parent or legal guardian, together with age-appropriate assent from the participant.

Exclusion criteria

Exclusion Criteria:

  1. Diagnosed cardiovascular, cerebrovascular, neurological, or other major systemic disease that may affect safe participation or study outcomes.
  2. Musculoskeletal injury, pain, or disorder that limits prolonged sitting, standing, walking, or performance of the seated exercise intervention.
  3. Acute illness, fever, or significant physical discomfort at the time of testing.
  4. History of syncope, severe dizziness, or other conditions that may increase the risk associated with prolonged sitting or exercise testing.
  5. Current use of medications that may substantially affect autonomic nervous system function, alertness, cognitive performance, or salivary stress biomarkers, unless considered clinically stable and acceptable by the investigators.
  6. Known allergy or significant skin sensitivity to electrodes or adhesive materials used for EEG, /HRV, or surface electromyography.
  7. Inability to adequately complete the cognitive assessment procedures because of communication, visual, auditory, or other functional limitations.
  8. Participation in vigorous exercise, alcohol consumption, or other behaviors inconsistent with the standardized pre-test requirements within the predefined period before testing.
  9. Any condition judged by the investigators to make participation unsafe or to substantially interfere with interpretation of the study outcomes.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Sequence AB: Seated Exercise Followed by Control

    Participants will first complete the seated exercise condition during Period 1. After a washout period of at least 7 days, they will complete the prolonged sitting control condition during Period 2.

    Behavioral: Standardized Age-Specific Seated Exercise Program

  • Experimental
    Sequence BA: Control Followed by Seated Exercise

    Participants will first complete the prolonged sitting control condition during Period 1. After a washout period of at least 7 days, they will complete the seated exercise condition during Period 2.

    Other: Prolonged Sitting Control

Interventions

  • BehavioralStandardized Age-Specific Seated Exercise Program

    A standardized seated exercise program designed for prolonged high-speed rail travel. The program consists of a predefined sequence of seated movements that can be performed within the spatial constraints of a high-speed rail seat. Age-specific instructional videos are used to standardize the exercise content, movement sequence, rhythm, duration, and instructions for participants aged 7-18 years, 18-45 years, and 45-60 years. During the seated exercise condition, participants perform the standardized exercise at the predefined intervention time point and approximately once every hour during the prolonged sitting period.

  • OtherProlonged Sitting Control

    Participants remain seated in the same simulated high-speed rail environment for approximately 7 hours and undergo the same assessment schedule as in the seated exercise condition, but do not perform the structured seated exercise program. Standardized brief breaks for essential needs, including restroom use, drinking water, and scheduled meals, are permitted and recorded. The duration and environmental conditions are standardized as far as practicable between the seated exercise and control conditions.

06

What researchers measure

Primary outcomes

  1. Change in Subjective Fatigue

    Subjective fatigue will be assessed using an age-appropriate Visual Analog Scale (VAS). Participants aged 7-18 years will use an age-adapted visual scale, while adult participants will use a standard VAS. Scores will be standardized to a 0-100 scale for analysis, with higher scores indicating greater subjective fatigue.

    Time frame: Baseline (T0), immediately after the initial intervention (T1), and at the end of the approximately 7-hour sitting session (T2)

Secondary outcomes

  1. Change in Subjective Sleepiness

    Subjective sleepiness will be assessed using the Karolinska Sleepiness Scale (KSS) or an age-adapted version for younger participants. Higher scores indicate greater sleepiness.

    Time frame: Baseline (T0), immediately after the initial intervention (T1), and at the end of the approximately 7-hour sitting session (T2)

  2. Change in Local Musculoskeletal Discomfort

    Local musculoskeletal discomfort will be assessed using a numerical rating scale or an age-appropriate facial rating scale. Higher scores indicate greater perceived discomfort or pain.

    Time frame: Baseline (T0), immediately after the initial intervention (T1), and at the end of the approximately 7-hour sitting session (T2)

  3. Change in Positive and Negative Affect

    Mood will be assessed using the Positive and Negative Affect Schedule (PANAS) or an age-adapted version for younger participants. Positive and negative affect scores will be analyzed separately.

    Time frame: Baseline (T0), immediately after the initial intervention (T1), and at the end of the approximately 7-hour sitting session (T2)

  4. Change in Psychomotor Vigilance

    Psychomotor vigilance will be assessed using a 3-minute Psychomotor Vigilance Task (PVT). Outcomes will include reaction time and lapses, with longer reaction times and more lapses indicating poorer vigilance.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  5. Change in Working Memory Performance

    Working memory will be assessed using an n-back task. Accuracy and reaction time will be recorded. Age-appropriate task difficulty will be used for younger participants.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  6. Change in Inhibitory Control Performance

    Inhibitory control will be assessed using a Stroop task. Accuracy, reaction time, and interference-related performance will be recorded using age-appropriate task versions.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  7. Change in Heart Rate Variability

    Autonomic nervous system function will be assessed using heart rate variability (HRV). Primary HRV indices will include RMSSD and SDNN.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  8. Change in Salivary Cortisol Concentration

    Salivary cortisol concentration will be measured as an indicator of physiological stress response.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  9. Change in Salivary Alpha-Amylase Activity

    Salivary alpha-amylase activity will be measured as an additional biomarker of physiological stress and autonomic activation.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  10. Change in Plantar Pressure and Postural Control

    Plantar pressure and postural control will be assessed using a plantar pressure platform. Outcomes will include plantar pressure distribution and center-of-pressure measures such as path length and mean velocity.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  11. Change in Surface Electromyographic Indicators of Muscle Fatigue

    Surface electromyography (sEMG) will be used to assess neuromuscular changes associated with prolonged sitting. Amplitude- and frequency-domain indicators of muscle activity and fatigue will be analyzed.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

  12. Change in Electroencephalographic Spectral Power

    Electroencephalography (EEG) will be used to assess neurophysiological changes associated with prolonged sitting and seated exercise. Spectral power in the theta, alpha, and beta frequency bands will be analyzed.

    Time frame: Baseline (T0) and at the end of the approximately 7-hour sitting session (T2)

07

Study locations

1 site
  • Jinan Public Works Section, China Railway
    Jinan, Shandong, China
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the main results of the study may be shared with qualified researchers upon reasonable request following publication of the primary study results. Shared data may include de-identified demographic, behavioral, physiological, and primary and secondary outcome data, subject to applicable ethical and data protection requirements.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available beginning 6 months after publication of the primary study results and will remain available for 5 years.

Access criteria: Data requests will be reviewed by the principal investigator and research team. Researchers requesting access should provide a scientifically justified research proposal, a data analysis plan, and evidence of appropriate ethical approval where applicable. Data will be shared only for legitimate scientific purposes and subject to a data use agreement and applicable privacy and ethical requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07922603
Lead sponsor
Aiyoudong Children and Youth Sports Health Research Institute
Collaborators
All-China Federation of Railway Trade Unions
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Aug 1, 2026
Primary completion
Oct 20, 2026
Completion
Oct 20, 2026
Last update
Nov 6, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion